Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pathology of borderline HER-2/neu breast carcinoma: a biologically distinct phenotype.

Breast cancer research and treatment - 1 Jul 2006

Killeen Jeffrey L, Ortega-Lopez Anna, Shaha James, Shaha Steven H, Fu Jennifer B

Abstract excerpt

PURPOSE: The significance of HER-2/neu results obtained by immunohistochemical analyses (IHC) which are neither negative nor strongly positive is controversial. The incidence of fluorescence in situ hybridization (FISH) positivity in these tumors is small and the implication is that these borderline results represent laboratory misclassification. We analyzed the tumor characteristics of these HER-2/neu borderline...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Gene Expression Regulation, Neoplastic

Share to Immunohistochemistry

Share to In Situ Hybridization, Fluorescence

Share to Phenotype

Source

Identifiers

PMID: 16538540
DOI: 10.1007/s10549-005-9136-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pathology of borderline HER-2/neu breast carcinoma: a biologically distinct phenotype.PMID 16538540Read ↗

The Prevalence of HER2 Positivity In HER2 Borderline Tumors In Iranian Breast Cancer Patients And Predictive VariablesSemantic proximity Read ↗

Triple-negative breast cancer: a threshold-defined diagnostic category within a biological continuum.Semantic proximity Read ↗

Exploring the Heterogeneity of HER2 gene status and Expression in Non-Positive Breast Cancer Patients: Insights from Immunohistochemistry and Fluorescence In Situ HybridizationSemantic proximity Read ↗

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.Semantic proximity Read ↗

Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers.Semantic proximity Read ↗

Unusual Patterns of HER2 Expression in Breast Cancer: Insights and PerspectivesSemantic proximity Read ↗

Clinical and pathologic aspects of basal-like breast cancers.Semantic proximity Read ↗

Do HER2-Low Tumors Have a Distinct Clinicopathologic Phenotype?Semantic proximity Read ↗

BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays.Semantic proximity Read ↗

Changing frequency of equivocal HER-2/neu scores and factors predictive of negative HER 2/neu fluorescent in situ hybridisation in invasive carcinomas of the breast.Semantic proximity Read ↗

Evaluation of morphologic features to identify "basal-like phenotype" on core needle biopsies of breast.Semantic proximity Read ↗

Comparison of mutations of Ki-RAS and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.